CB Insights
Technology Market Intelligence
Technology Market Intelligence
Karyopharm Therapeutics is a clinical-stage pharmaceutical company developing small molecule modulators of nuclear transport. Karyopharm's selective inhibitors of nuclear export (SINE) function by trapping multiple tumor suppressor proteins in the nu...Show all
Company (IPO / Went public)
Phone: +1 617 658 0600
85 Wells Avenue
2/F
Newton Center, 02459
Massachusetts, United States
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Name | Firm |
|---|---|
| Login to see details | Delphi Ventures |
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Substituted 2,3-dihydrobenzofuranyl compounds and uses thereof | Nov 27, 2013 | Apr 10, 2018 | Patent |
| Nuclear transport modulators and uses thereof | Jun 23, 2015 | Jan 09, 2018 | Patent |
| Substituted benzofuranyl and benzoxazolyl compounds and uses thereof | Jul 03, 2014 | Jan 02, 2018 | Patent |
| Nuclear transport modulators and uses thereof | Jun 20, 2014 | Aug 22, 2017 | Patent |
| Hydrazide containing nuclear transport modulators and uses thereof | Nov 13, 2015 | Jul 25, 2017 | Patent |
